In a revealing Genomic Press Interview published coming successful Brain Medicine, Dr. Camilo de la Fuente-Sandoval shares really individual history and technological passion converged to create groundbreaking advances successful schizophrenia curen prediction. The distinguished neuroscientist, precocious honored pinch nan Schizophrenia International Research Society's prestigious 2024 Global Schizophrenia Award, has established a unsocial investigation paradigm that combines cutting-edge neuroimaging pinch broad objective attraction successful 1 of Latin America's astir populous municipality centers.
From governmental exile to technological excellence
The travel that led Dr. de la Fuente-Sandoval to go a starring sound successful psychosis investigation began pinch displacement. His father, a interrogator forced to fly Chile for governmental reasons, saw his technological profession abruptly terminated. This family history of interrupted technological pursuit became a driving unit that would later style nan younger de la Fuente-Sandoval's determination to build thing lasting successful neuroscience research.
During his psychiatry residency astatine nan Instituto Nacional de Neurología y Neurocirugía, patients experiencing psychosis captivated his attention. Guided by chap resident Ariel Graff-Guerrero, who had completed precocious neuroscience training, Dr. de la Fuente-Sandoval embarked connected spectroscopy studies that would fundamentally change knowing of early psychosis mechanisms. These first investigations successful some objective high-risk subjects and first-episode psychosis patients revealed neurochemical alterations that had antecedently remained hidden from objective observation.
The occurrence of these early studies prompted organization activity to connection him laboratory space, catalyzing nan creation of what would go nan Laboratory of Experimental Psychiatry. This opportunity sparked an eager vision: processing imaging markers that could guideline curen action alternatively than relying connected nan accepted trial-and-error attack that often delays effective involution successful young group experiencing their first psychotic episodes.
Revolutionary attraction exemplary successful resource-limited settings
Operating wrong Mexico City's sprawling metropolitan area of 22 cardinal residents, wherever intelligence wellness resources stay severely limited, Dr. de la Fuente-Sandoval has engineered an innovative objective investigation ecosystem. His squad established a specialized outpatient session staffed by laboratory-affiliated psychiatrists while simultaneously implementing broad information protocols successful nan emergency department.
This integrated attack ensures that first-episode psychosis patients person immediate, thorough appraisal including regular laboratory tests, caput CT scans, and selective lumbar punctures based connected objective judgment. Remarkably, astir 8% of patients presenting pinch first-episode psychosis are discovered to person secondary causes specified arsenic viral encephalitis aliases autoimmune conditions. Could this systematic screening approach, if implemented much broadly, forestall misdiagnosis and inappropriate curen successful akin diligent populations worldwide?
All patients acquisition broad information wrong 24 hours of emergency admission, including neuropsychological testing and MRI studies. This accelerated appraisal protocol serves dual purposes: enabling contiguous curen initiation while generating important investigation data. The full process occurs astatine nary costs to patients, addressing some technological questions and healthcare entree barriers simultaneously.
Glutamate: The missing portion successful curen prediction
The laboratory's astir important publication centers connected discoveries astir glutamate dysfunction successful early psychosis. Through blase MRI spectroscopy techniques applied to antipsychotic-naïve patients, Dr. de la Fuente-Sandoval's squad identified elevated glutamate levels specifically wrong nan associative striatum. More importantly, they demonstrated that these elevations normalize pursuing effective antipsychotic treatment.
This uncovering opens unprecedented possibilities for curen personalization. Rather than subjecting patients to perchance ineffective medications for weeks aliases months, clinicians mightiness soon foretell curen consequence done baseline neuroimaging assessments. What implications mightiness this clasp for reducing nan long of untreated psychosis, a facet powerfully associated pinch semipermanent outcomes? The imaginable to lucifer patients pinch optimal treatments from nan outset represents a paradigm displacement successful psychiatric attraction delivery.
The investigation extends beyond glutamate to encompass electrophysiology, cognitive assessment, and inflammation markers. This multidimensional attack recognizes psychosis arsenic a analyzable arena requiring arsenic blase investigative strategies. By integrating aggregate biologic markers, nan laboratory useful toward broad predictive models that could toggle shape objective decision-making.
Building world collaborations from nan world South
Despite geographic and assets constraints, Dr. de la Fuente-Sandoval has positioned his laboratory astatine nan forefront of world schizophrenia research. His activity domiciled successful nan ENIGMA Clinical High Risk for Psychosis Working Group facilitates information sharing and collaborative analyses crossed continents. This information ensures that findings from Latin American populations lend to world knowing of psychosis mechanisms.
The laboratory's occurrence challenges assumptions astir wherever cutting-edge neuroscience tin flourish. By leveraging Mexico City's ample diligent organization and combining it pinch rigorous technological methodology, nan squad generates insights unavailable successful better-resourced but smaller investigation settings. How mightiness different investigators successful resource-limited environments replicate this exemplary of turning evident disadvantages into technological opportunities?
Dr. de la Fuente-Sandoval's Genomic Press question and reply is portion of a larger bid called Innovators & Ideas that highlights nan group down today's astir influential technological breakthroughs. Each question and reply successful nan bid offers a blend of cutting-edge investigation and individual reflections, providing readers pinch a broad position of nan scientists shaping nan future. By combining a attraction connected master achievements pinch individual insights, this question and reply style invites a richer communicative that some engages and educates readers. This format provides an perfect starting constituent for profiles that research nan scientist's effect connected nan field, while besides rubbing connected broader quality themes. More accusation connected nan investigation leaders and rising stars featured successful our Innovators & Ideas -- Genomic Press Interview bid tin beryllium recovered successful our publications website: https://genomicpress.kglmeridian.com/.
Source:
Journal reference:
de la Fuente-Sandoval, C., (2025) Camilo de la Fuente-Sandoval: Glutamate arsenic biomarker of curen consequence successful early-stage schizophrenia. Brain Medicine. https://doi.org/10.61373/bm025k.0092.